DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,573,911 | -4.1% | 22,466 | -7.2% | 0.22% | +1.8% |
| Q2 2023 | $5,812,651 | -10.3% | 24,219 | -5.8% | 0.22% | -14.8% |
| Q1 2023 | $6,481,003 | -6.7% | 25,714 | -0.4% | 0.26% | -7.6% |
| Q4 2022 | $6,944,559 | +1.5% | 25,816 | -2.6% | 0.28% | -9.2% |
| Q3 2022 | $6,843,000 | +2.6% | 26,496 | +0.7% | 0.31% | +6.2% |
| Q2 2022 | $6,672,000 | -13.1% | 26,323 | +0.5% | 0.29% | +4.3% |
| Q1 2022 | $7,681,000 | -11.2% | 26,192 | -0.4% | 0.28% | -5.5% |
| Q4 2021 | $8,654,000 | +6.7% | 26,306 | -1.3% | 0.29% | -1.4% |
| Q3 2021 | $8,109,000 | +11.8% | 26,640 | -1.4% | 0.30% | +13.8% |
| Q2 2021 | $7,253,000 | +15.2% | 27,030 | -4.0% | 0.26% | +8.3% |
| Q1 2021 | $6,297,000 | -0.8% | 28,144 | -1.5% | 0.24% | -17.5% |
| Q4 2020 | $6,347,000 | -0.3% | 28,579 | -3.4% | 0.29% | +1.0% |
| Q3 2020 | $6,368,000 | +20.3% | 29,577 | -1.2% | 0.29% | +14.3% |
| Q2 2020 | $5,295,000 | +13.7% | 29,951 | -11.0% | 0.25% | -4.5% |
| Q1 2020 | $4,658,000 | -8.5% | 33,663 | +1.5% | 0.26% | +17.3% |
| Q4 2019 | $5,090,000 | -0.2% | 33,166 | -6.1% | 0.22% | -3.4% |
| Q3 2019 | $5,101,000 | +1.8% | 35,327 | +0.8% | 0.23% | +2.2% |
| Q2 2019 | $5,009,000 | +6.6% | 35,056 | -1.5% | 0.23% | +4.1% |
| Q1 2019 | $4,699,000 | +26.0% | 35,602 | -1.6% | 0.22% | +7.9% |
| Q4 2018 | $3,729,000 | -5.5% | 36,173 | -0.4% | 0.20% | +11.5% |
| Q3 2018 | $3,945,000 | +8.8% | 36,311 | -1.2% | 0.18% | +4.6% |
| Q2 2018 | $3,627,000 | -2.9% | 36,764 | -3.7% | 0.17% | -2.8% |
| Q1 2018 | $3,737,000 | -16.9% | 38,178 | -11.4% | 0.18% | -12.7% |
| Q4 2017 | $4,497,000 | +9.4% | 43,075 | -10.8% | 0.20% | +5.1% |
| Q3 2017 | $4,110,000 | +1.3% | 48,301 | +0.5% | 0.20% | -1.0% |
| Q2 2017 | $4,057,000 | -1.4% | 48,075 | -0.1% | 0.20% | -3.4% |
| Q1 2017 | $4,113,000 | +1.5% | 48,101 | -7.6% | 0.20% | 0.0% |
| Q4 2016 | $4,052,000 | +17.8% | 52,056 | +18.6% | 0.20% | +9.1% |
| Q3 2016 | $3,439,000 | +18.1% | 43,881 | +52.1% | 0.19% | -1.1% |
| Q2 2016 | $2,913,000 | +8.2% | 28,857 | +1.6% | 0.19% | +5.6% |
| Q1 2016 | $2,693,000 | -26.4% | 28,405 | -27.9% | 0.18% | -27.5% |
| Q4 2015 | $3,660,000 | -11.3% | 39,412 | -18.7% | 0.25% | -16.6% |
| Q3 2015 | $4,127,000 | -1.4% | 48,449 | -0.9% | 0.30% | +7.6% |
| Q2 2015 | $4,184,000 | +0.5% | 48,897 | -0.3% | 0.28% | +1.1% |
| Q1 2015 | $4,165,000 | -0.5% | 49,066 | +0.4% | 0.27% | -5.2% |
| Q4 2014 | $4,187,000 | +21.8% | 48,864 | +7.9% | 0.29% | +16.7% |
| Q3 2014 | $3,439,000 | +6.3% | 45,274 | +10.1% | 0.25% | +5.6% |
| Q2 2014 | $3,236,000 | +12.1% | 41,110 | +6.8% | 0.23% | +2.6% |
| Q1 2014 | $2,887,000 | -4.5% | 38,510 | -1.7% | 0.23% | -5.8% |
| Q4 2013 | $3,022,000 | +12.0% | 39,161 | +0.6% | 0.24% | -4.7% |
| Q3 2013 | $2,699,000 | -99.8% | 38,936 | +48.2% | 0.25% | -44.4% |
| Q2 2013 | $1,663,524,000 | – | 26,280 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |